Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation

It is still debated whether prophylactic doses of low-molecular- weight heparin (LMWH) are always effective in preventing Venous Thromboembolism (VTE) and mortality in COVID-19. Furthermore, there is paucity of data for those patients not requiring ventilation. We explored mortality and the safety/e...

Descripción completa

Detalles Bibliográficos
Autores principales: Grandone, Elvira, Tiscia, Giovanni, Pesavento, Raffaele, De Laurenzo, Antonio, Ceccato, Davide, Sartori, Maria Teresa, Mirabella, Lucia, Cinnella, Gilda, Mastroianno, Mario, Dalfino, Lidia, Colaizzo, Donatella, Vettor, Roberto, Intrieri, Mariano, Ostuni, Angelo, Margaglione, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040353/
https://www.ncbi.nlm.nih.gov/pubmed/33844150
http://dx.doi.org/10.1007/s11239-021-02429-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040353/
https://www.ncbi.nlm.nih.gov/pubmed/33844150
http://dx.doi.org/10.1007/s11239-021-02429-z

Ejemplares similares